Acupuncture anesthesia

Gene symbol: Fgfr2

Also known as: KGFR

Organism: Rattus norvegicus

Summary: Enables fibroblast growth factor binding activity and fibroblast growth factor-activated receptor activity. Involved in several processes, including cellular response to growth factor stimulus; cellular response to retinoic acid; and positive regulation of smooth muscle cell proliferation. Located in cell surface; cytoplasm; and nucleus. Used to study prostate cancer and retinitis pigmentosa. Biomarker of hypospadias. Human ortholog(s) of this gene implicated in several diseases, including Beare-Stevenson cutis gyrata syndrome; Jackson-Weiss syndrome; LADD syndrome; dysgerminoma; and synostosis (multiple). Orthologous to human FGFR2 (fibroblast growth factor receptor 2). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 25022 Ensembl:ENSRNOG00000016374 AllianceGenome:RGD:2611

GO Annotation

Category	Term ID	Term description
Process	GO:0000003	Reproduction
Process	GO:0000122	Negative regulation of transcription by RNA polymerase II
Process	GO:0000902	Cell morphogenesis
Process	GO:0000904	Cell morphogenesis involved in differentiation
Process	GO:0001501	Skeletal system development
Process	GO:0001503	Ossification
Process	GO:0001525	Angiogenesis
Process	GO:0001568	Blood vessel development
Process	GO:0001654	Eye development
Process	GO:0001655	Urogenital system development
Process	GO:0001657	Ureteric bud development
Process	GO:0001701	In utero embryonic development
Process	GO:0001704	Formation of primary germ layer
Process	GO:0001707	Mesoderm formation
Process	GO:0001763	Morphogenesis of a branching structure
Process	GO:0001822	Kidney development
Process	GO:0001823	Mesonephros development
Process	GO:0001837	Epithelial to mesenchymal transition
Process	GO:0001890	Placenta development
Process	GO:0001892	Embryonic placenta development
Process	GO:0001942	Hair follicle development
Process	GO:0001944	Vasculature development
Process	GO:0002009	Morphogenesis of an epithelium
Process	GO:0002053	Positive regulation of mesenchymal cell proliferation
Process	GO:0002064	Epithelial cell development
Process	GO:0002065	Columnar/cuboidal epithelial cell differentiation
Process	GO:0002067	Glandular epithelial cell differentiation
Process	GO:0002088	Lens development in camera-type eye
Process	GO:0002237	Response to molecule of bacterial origin
Process	GO:0002376	Immune system process
Process	GO:0002520	Immune system development
Process	GO:0003002	Regionalization
Process	GO:0003006	Developmental process involved in reproduction
Process	GO:0003007	Heart morphogenesis
Process	GO:0003148	Outflow tract septum morphogenesis
Process	GO:0003149	Membranous septum morphogenesis
Process	GO:0003151	Outflow tract morphogenesis
Process	GO:0003205	Cardiac chamber development
Process	GO:0003206	Cardiac chamber morphogenesis
Process	GO:0003208	Cardiac ventricle morphogenesis
Process	GO:0003229	Ventricular cardiac muscle tissue development
Process	GO:0003231	Cardiac ventricle development
Process	GO:0003279	Cardiac septum development
Process	GO:0003281	Ventricular septum development
Process	GO:0003401	Axis elongation
Process	GO:0003416	Endochondral bone growth
Process	GO:0006355	Regulation of transcription, DNA-templated
Process	GO:0006357	Regulation of transcription by RNA polymerase II
Process	GO:0006468	Protein phosphorylation
Process	GO:0006793	Phosphorus metabolic process
Process	GO:0006796	Phosphate-containing compound metabolic process
Process	GO:0006807	Nitrogen compound metabolic process
Process	GO:0006810	Transport
Process	GO:0006950	Response to stress
Process	GO:0007088	Regulation of mitotic nuclear division
Process	GO:0007154	Cell communication
Process	GO:0007165	Signal transduction
Process	GO:0007166	Cell surface receptor signaling pathway
Process	GO:0007167	Enzyme-linked receptor protein signaling pathway
Process	GO:0007169	Transmembrane receptor protein tyrosine kinase signaling pathway
Process	GO:0007267	Cell-cell signaling
Process	GO:0007275	Multicellular organism development
Process	GO:0007346	Regulation of mitotic cell cycle
Process	GO:0007369	Gastrulation
Process	GO:0007389	Pattern specification process
Process	GO:0007399	Nervous system development
Process	GO:0007405	Neuroblast proliferation
Process	GO:0007409	Axonogenesis
Process	GO:0007417	Central nervous system development
Process	GO:0007420	Brain development
Process	GO:0007423	Sensory organ development
Process	GO:0007431	Salivary gland development
Process	GO:0007435	Salivary gland morphogenesis
Process	GO:0007498	Mesoderm development
Process	GO:0007507	Heart development
Process	GO:0007517	Muscle organ development
Process	GO:0007528	Neuromuscular junction development
Process	GO:0008152	Metabolic process
Process	GO:0008283	Cell population proliferation
Process	GO:0008284	Positive regulation of cell population proliferation
Process	GO:0008285	Negative regulation of cell population proliferation
Process	GO:0008543	Fibroblast growth factor receptor signaling pathway
Process	GO:0008544	Epidermis development
Process	GO:0008589	Regulation of smoothened signaling pathway
Process	GO:0009605	Response to external stimulus
Process	GO:0009607	Response to biotic stimulus
Process	GO:0009611	Response to wounding
Process	GO:0009617	Response to bacterium
Process	GO:0009653	Anatomical structure morphogenesis
Process	GO:0009719	Response to endogenous stimulus
Process	GO:0009790	Embryo development
Process	GO:0009791	Post-embryonic development
Process	GO:0009792	Embryo development ending in birth or egg hatching
Process	GO:0009880	Embryonic pattern specification
Process	GO:0009887	Animal organ morphogenesis
Process	GO:0009888	Tissue development
Process	GO:0009889	Regulation of biosynthetic process
Process	GO:0009890	Negative regulation of biosynthetic process
Process	GO:0009891	Positive regulation of biosynthetic process
Process	GO:0009892	Negative regulation of metabolic process
Process	GO:0009893	Positive regulation of metabolic process
Process	GO:0009966	Regulation of signal transduction
Process	GO:0009967	Positive regulation of signal transduction
Process	GO:0009987	Cellular process
Process	GO:0010033	Response to organic substance
Process	GO:0010092	Specification of animal organ identity
Process	GO:0010463	Mesenchymal cell proliferation
Process	GO:0010464	Regulation of mesenchymal cell proliferation
Process	GO:0010468	Regulation of gene expression
Process	GO:0010517	Regulation of phospholipase activity
Process	GO:0010518	Positive regulation of phospholipase activity
Process	GO:0010556	Regulation of macromolecule biosynthetic process
Process	GO:0010557	Positive regulation of macromolecule biosynthetic process
Process	GO:0010558	Negative regulation of macromolecule biosynthetic process
Process	GO:0010562	Positive regulation of phosphorus metabolic process
Process	GO:0010564	Regulation of cell cycle process
Process	GO:0010604	Positive regulation of macromolecule metabolic process
Process	GO:0010605	Negative regulation of macromolecule metabolic process
Process	GO:0010628	Positive regulation of gene expression
Process	GO:0010639	Negative regulation of organelle organization
Process	GO:0010646	Regulation of cell communication
Process	GO:0010647	Positive regulation of cell communication
Process	GO:0010837	Regulation of keratinocyte proliferation
Process	GO:0010839	Negative regulation of keratinocyte proliferation
Process	GO:0010941	Regulation of cell death
Process	GO:0010948	Negative regulation of cell cycle process
Process	GO:0014706	Striated muscle tissue development
Process	GO:0016043	Cellular component organization
Process	GO:0016310	Phosphorylation
Process	GO:0016331	Morphogenesis of embryonic epithelium
Process	GO:0018108	Peptidyl-tyrosine phosphorylation
Process	GO:0018193	Peptidyl-amino acid modification
Process	GO:0018212	Peptidyl-tyrosine modification
Process	GO:0019219	Regulation of nucleobase-containing compound metabolic process
Process	GO:0019220	Regulation of phosphate metabolic process
Process	GO:0019222	Regulation of metabolic process
Process	GO:0019538	Protein metabolic process
Process	GO:0021761	Limbic system development
Process	GO:0021769	Orbitofrontal cortex development
Process	GO:0021846	Cell proliferation in forebrain
Process	GO:0021847	Ventricular zone neuroblast division
Process	GO:0021859	Pyramidal neuron differentiation
Process	GO:0021860	Pyramidal neuron development
Process	GO:0021869	Forebrain ventricular zone progenitor cell division
Process	GO:0021872	Forebrain generation of neurons
Process	GO:0021873	Forebrain neuroblast division
Process	GO:0021879	Forebrain neuron differentiation
Process	GO:0021884	Forebrain neuron development
Process	GO:0021953	Central nervous system neuron differentiation
Process	GO:0021954	Central nervous system neuron development
Process	GO:0022008	Neurogenesis
Process	GO:0022404	Molting cycle process
Process	GO:0022405	Hair cycle process
Process	GO:0022414	Reproductive process
Process	GO:0022603	Regulation of anatomical structure morphogenesis
Process	GO:0022612	Gland morphogenesis
Process	GO:0023051	Regulation of signaling
Process	GO:0023052	Signaling
Process	GO:0023056	Positive regulation of signaling
Process	GO:0030030	Cell projection organization
Process	GO:0030097	Hemopoiesis
Process	GO:0030111	Regulation of Wnt signaling pathway
Process	GO:0030154	Cell differentiation
Process	GO:0030177	Positive regulation of Wnt signaling pathway
Process	GO:0030182	Neuron differentiation
Process	GO:0030282	Bone mineralization
Process	GO:0030323	Respiratory tube development
Process	GO:0030324	Lung development
Process	GO:0030850	Prostate gland development
Process	GO:0030855	Epithelial cell differentiation
Process	GO:0030879	Mammary gland development
Process	GO:0030900	Forebrain development
Process	GO:0030901	Midbrain development
Process	GO:0030916	Otic vesicle formation
Process	GO:0031069	Hair follicle morphogenesis
Process	GO:0031175	Neuron projection development
Process	GO:0031214	Biomineral tissue development
Process	GO:0031323	Regulation of cellular metabolic process
Process	GO:0031324	Negative regulation of cellular metabolic process
Process	GO:0031325	Positive regulation of cellular metabolic process
Process	GO:0031326	Regulation of cellular biosynthetic process
Process	GO:0031327	Negative regulation of cellular biosynthetic process
Process	GO:0031328	Positive regulation of cellular biosynthetic process
Process	GO:0032496	Response to lipopolysaccharide
Process	GO:0032501	Multicellular organismal process
Process	GO:0032502	Developmental process
Process	GO:0032526	Response to retinoic acid
Process	GO:0032808	Lacrimal gland development
Process	GO:0032989	Cellular component morphogenesis
Process	GO:0032990	Cell part morphogenesis
Process	GO:0033043	Regulation of organelle organization
Process	GO:0033674	Positive regulation of kinase activity
Process	GO:0033993	Response to lipid
Process	GO:0034330	Cell junction organization
Process	GO:0035107	Appendage morphogenesis
Process	GO:0035108	Limb morphogenesis
Process	GO:0035148	Tube formation
Process	GO:0035239	Tube morphogenesis
Process	GO:0035265	Organ growth
Process	GO:0035272	Exocrine system development
Process	GO:0035295	Tube development
Process	GO:0035607	Fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development
Process	GO:0036211	Protein modification process
Process	GO:0040007	Growth
Process	GO:0040008	Regulation of growth
Process	GO:0042060	Wound healing
Process	GO:0042127	Regulation of cell population proliferation
Process	GO:0042221	Response to chemical
Process	GO:0042303	Molting cycle
Process	GO:0042325	Regulation of phosphorylation
Process	GO:0042327	Positive regulation of phosphorylation
Process	GO:0042471	Ear morphogenesis
Process	GO:0042472	Inner ear morphogenesis
Process	GO:0042476	Odontogenesis
Process	GO:0042633	Hair cycle
Process	GO:0042981	Regulation of apoptotic process
Process	GO:0043009	Chordate embryonic development
Process	GO:0043010	Camera-type eye development
Process	GO:0043066	Negative regulation of apoptotic process
Process	GO:0043067	Regulation of programmed cell death
Process	GO:0043069	Negative regulation of programmed cell death
Process	GO:0043085	Positive regulation of catalytic activity
Process	GO:0043170	Macromolecule metabolic process
Process	GO:0043207	Response to external biotic stimulus
Process	GO:0043408	Regulation of MAPK cascade
Process	GO:0043410	Positive regulation of MAPK cascade
Process	GO:0043412	Macromolecule modification
Process	GO:0043549	Regulation of kinase activity
Process	GO:0043583	Ear development
Process	GO:0043588	Skin development
Process	GO:0044093	Positive regulation of molecular function
Process	GO:0044237	Cellular metabolic process
Process	GO:0044238	Primary metabolic process
Process	GO:0044344	Cellular response to fibroblast growth factor stimulus
Process	GO:0044419	Biological process involved in interspecies interaction between organisms
Process	GO:0045165	Cell fate commitment
Process	GO:0045471	Response to ethanol
Process	GO:0045595	Regulation of cell differentiation
Process	GO:0045786	Negative regulation of cell cycle
Process	GO:0045787	Positive regulation of cell cycle
Process	GO:0045839	Negative regulation of mitotic nuclear division
Process	GO:0045892	Negative regulation of transcription, DNA-templated
Process	GO:0045893	Positive regulation of transcription, DNA-templated
Process	GO:0045927	Positive regulation of growth
Process	GO:0045930	Negative regulation of mitotic cell cycle
Process	GO:0045934	Negative regulation of nucleobase-containing compound metabolic process
Process	GO:0045935	Positive regulation of nucleobase-containing compound metabolic process
Process	GO:0045937	Positive regulation of phosphate metabolic process
Process	GO:0045944	Positive regulation of transcription by RNA polymerase II
Process	GO:0046620	Regulation of organ growth
Process	GO:0046622	Positive regulation of organ growth
Process	GO:0046777	Protein autophosphorylation
Process	GO:0048286	Lung alveolus development
Process	GO:0048332	Mesoderm morphogenesis
Process	GO:0048333	Mesodermal cell differentiation
Process	GO:0048468	Cell development
Process	GO:0048489	Synaptic vesicle transport
Process	GO:0048513	Animal organ development
Process	GO:0048514	Blood vessel morphogenesis
Process	GO:0048518	Positive regulation of biological process
Process	GO:0048519	Negative regulation of biological process
Process	GO:0048522	Positive regulation of cellular process
Process	GO:0048523	Negative regulation of cellular process
Process	GO:0048534	Hematopoietic or lymphoid organ development
Process	GO:0048546	Digestive tract morphogenesis
Process	GO:0048557	Embryonic digestive tract morphogenesis
Process	GO:0048562	Embryonic organ morphogenesis
Process	GO:0048565	Digestive tract development
Process	GO:0048566	Embryonic digestive tract development
Process	GO:0048568	Embryonic organ development
Process	GO:0048583	Regulation of response to stimulus
Process	GO:0048584	Positive regulation of response to stimulus
Process	GO:0048589	Developmental growth
Process	GO:0048598	Embryonic morphogenesis
Process	GO:0048608	Reproductive structure development
Process	GO:0048638	Regulation of developmental growth
Process	GO:0048639	Positive regulation of developmental growth
Process	GO:0048644	Muscle organ morphogenesis
Process	GO:0048645	Animal organ formation
Process	GO:0048646	Anatomical structure formation involved in morphogenesis
Process	GO:0048660	Regulation of smooth muscle cell proliferation
Process	GO:0048661	Positive regulation of smooth muscle cell proliferation
Process	GO:0048666	Neuron development
Process	GO:0048667	Cell morphogenesis involved in neuron differentiation
Process	GO:0048699	Generation of neurons
Process	GO:0048701	Embryonic cranial skeleton morphogenesis
Process	GO:0048704	Embryonic skeletal system morphogenesis
Process	GO:0048705	Skeletal system morphogenesis
Process	GO:0048706	Embryonic skeletal system development
Process	GO:0048729	Tissue morphogenesis
Process	GO:0048730	Epidermis morphogenesis
Process	GO:0048731	System development
Process	GO:0048732	Gland development
Process	GO:0048736	Appendage development
Process	GO:0048738	Cardiac muscle tissue development
Process	GO:0048754	Branching morphogenesis of an epithelial tube
Process	GO:0048755	Branching morphogenesis of a nerve
Process	GO:0048762	Mesenchymal cell differentiation
Process	GO:0048812	Neuron projection morphogenesis
Process	GO:0048839	Inner ear development
Process	GO:0048856	Anatomical structure development
Process	GO:0048858	Cell projection morphogenesis
Process	GO:0048863	Stem cell differentiation
Process	GO:0048869	Cellular developmental process
Process	GO:0048880	Sensory system development
Process	GO:0050673	Epithelial cell proliferation
Process	GO:0050678	Regulation of epithelial cell proliferation
Process	GO:0050679	Positive regulation of epithelial cell proliferation
Process	GO:0050680	Negative regulation of epithelial cell proliferation
Process	GO:0050789	Regulation of biological process
Process	GO:0050790	Regulation of catalytic activity
Process	GO:0050793	Regulation of developmental process
Process	GO:0050794	Regulation of cellular process
Process	GO:0050808	Synapse organization
Process	GO:0050896	Response to stimulus
Process	GO:0051094	Positive regulation of developmental process
Process	GO:0051128	Regulation of cellular component organization
Process	GO:0051129	Negative regulation of cellular component organization
Process	GO:0051147	Regulation of muscle cell differentiation
Process	GO:0051150	Regulation of smooth muscle cell differentiation
Process	GO:0051171	Regulation of nitrogen compound metabolic process
Process	GO:0051172	Negative regulation of nitrogen compound metabolic process
Process	GO:0051173	Positive regulation of nitrogen compound metabolic process
Process	GO:0051174	Regulation of phosphorus metabolic process
Process	GO:0051179	Localization
Process	GO:0051234	Establishment of localization
Process	GO:0051239	Regulation of multicellular organismal process
Process	GO:0051240	Positive regulation of multicellular organismal process
Process	GO:0051252	Regulation of RNA metabolic process
Process	GO:0051253	Negative regulation of RNA metabolic process
Process	GO:0051254	Positive regulation of RNA metabolic process
Process	GO:0051301	Cell division
Process	GO:0051302	Regulation of cell division
Process	GO:0051336	Regulation of hydrolase activity
Process	GO:0051338	Regulation of transferase activity
Process	GO:0051345	Positive regulation of hydrolase activity
Process	GO:0051347	Positive regulation of transferase activity
Process	GO:0051640	Organelle localization
Process	GO:0051641	Cellular localization
Process	GO:0051648	Vesicle localization
Process	GO:0051649	Establishment of localization in cell
Process	GO:0051650	Establishment of vesicle localization
Process	GO:0051656	Establishment of organelle localization
Process	GO:0051707	Response to other organism
Process	GO:0051716	Cellular response to stimulus
Process	GO:0051726	Regulation of cell cycle
Process	GO:0051781	Positive regulation of cell division
Process	GO:0051783	Regulation of nuclear division
Process	GO:0051784	Negative regulation of nuclear division
Process	GO:0055008	Cardiac muscle tissue morphogenesis
Process	GO:0055010	Ventricular cardiac muscle tissue morphogenesis
Process	GO:0055021	Regulation of cardiac muscle tissue growth
Process	GO:0055023	Positive regulation of cardiac muscle tissue growth
Process	GO:0055057	Neuroblast division
Process	GO:0055123	Digestive system development
Process	GO:0060043	Regulation of cardiac muscle cell proliferation
Process	GO:0060045	Positive regulation of cardiac muscle cell proliferation
Process	GO:0060173	Limb development
Process	GO:0060174	Limb bud formation
Process	GO:0060191	Regulation of lipase activity
Process	GO:0060193	Positive regulation of lipase activity
Process	GO:0060255	Regulation of macromolecule metabolic process
Process	GO:0060322	Head development
Process	GO:0060348	Bone development
Process	GO:0060349	Bone morphogenesis
Process	GO:0060363	Cranial suture morphogenesis
Process	GO:0060411	Cardiac septum morphogenesis
Process	GO:0060412	Ventricular septum morphogenesis
Process	GO:0060415	Muscle tissue morphogenesis
Process	GO:0060420	Regulation of heart growth
Process	GO:0060421	Positive regulation of heart growth
Process	GO:0060425	Lung morphogenesis
Process	GO:0060429	Epithelium development
Process	GO:0060441	Epithelial tube branching involved in lung morphogenesis
Process	GO:0060442	Branching involved in prostate gland morphogenesis
Process	GO:0060443	Mammary gland morphogenesis
Process	GO:0060445	Branching involved in salivary gland morphogenesis
Process	GO:0060449	Bud elongation involved in lung branching
Process	GO:0060462	Lung lobe development
Process	GO:0060463	Lung lobe morphogenesis
Process	GO:0060484	Lung-associated mesenchyme development
Process	GO:0060485	Mesenchyme development
Process	GO:0060501	Positive regulation of epithelial cell proliferation involved in lung morphogenesis
Process	GO:0060512	Prostate gland morphogenesis
Process	GO:0060523	Prostate epithelial cord elongation
Process	GO:0060525	Prostate glandular acinus development
Process	GO:0060526	Prostate glandular acinus morphogenesis
Process	GO:0060527	Prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis
Process	GO:0060529	Squamous basal epithelial stem cell differentiation involved in prostate gland acinus development
Process	GO:0060537	Muscle tissue development
Process	GO:0060541	Respiratory system development
Process	GO:0060548	Negative regulation of cell death
Process	GO:0060560	Developmental growth involved in morphogenesis
Process	GO:0060562	Epithelial tube morphogenesis
Process	GO:0060571	Morphogenesis of an epithelial fold
Process	GO:0060572	Morphogenesis of an epithelial bud
Process	GO:0060592	Mammary gland formation
Process	GO:0060594	Mammary gland specification
Process	GO:0060595	Fibroblast growth factor receptor signaling pathway involved in mammary gland specification
Process	GO:0060601	Lateral sprouting from an epithelium
Process	GO:0060602	Branch elongation of an epithelium
Process	GO:0060603	Mammary gland duct morphogenesis
Process	GO:0060615	Mammary gland bud formation
Process	GO:0060648	Mammary gland bud morphogenesis
Process	GO:0060664	Epithelial cell proliferation involved in salivary gland morphogenesis
Process	GO:0060667	Branch elongation involved in salivary gland morphogenesis
Process	GO:0060669	Embryonic placenta morphogenesis
Process	GO:0060670	Branching involved in labyrinthine layer morphogenesis
Process	GO:0060688	Regulation of morphogenesis of a branching structure
Process	GO:0060711	Labyrinthine layer development
Process	GO:0060713	Labyrinthine layer morphogenesis
Process	GO:0060736	Prostate gland growth
Process	GO:0060737	Prostate gland morphogenetic growth
Process	GO:0060740	Prostate gland epithelium morphogenesis
Process	GO:0060742	Epithelial cell differentiation involved in prostate gland development
Process	GO:0060828	Regulation of canonical Wnt signaling pathway
Process	GO:0060915	Mesenchymal cell differentiation involved in lung development
Process	GO:0060916	Mesenchymal cell proliferation involved in lung development
Process	GO:0061031	Endodermal digestive tract morphogenesis
Process	GO:0061061	Muscle structure development
Process	GO:0061138	Morphogenesis of a branching epithelium
Process	GO:0061180	Mammary gland epithelium development
Process	GO:0061351	Neural precursor cell proliferation
Process	GO:0061458	Reproductive system development
Process	GO:0061564	Axon development
Process	GO:0065007	Biological regulation
Process	GO:0065009	Regulation of molecular function
Process	GO:0070306	Lens fiber cell differentiation
Process	GO:0070307	Lens fiber cell development
Process	GO:0070372	Regulation of ERK1 and ERK2 cascade
Process	GO:0070374	Positive regulation of ERK1 and ERK2 cascade
Process	GO:0070848	Response to growth factor
Process	GO:0070887	Cellular response to chemical stimulus
Process	GO:0071300	Cellular response to retinoic acid
Process	GO:0071310	Cellular response to organic substance
Process	GO:0071363	Cellular response to growth factor stimulus
Process	GO:0071396	Cellular response to lipid
Process	GO:0071495	Cellular response to endogenous stimulus
Process	GO:0071559	Response to transforming growth factor beta
Process	GO:0071560	Cellular response to transforming growth factor beta stimulus
Process	GO:0071599	Otic vesicle development
Process	GO:0071600	Otic vesicle morphogenesis
Process	GO:0071704	Organic substance metabolic process
Process	GO:0071774	Response to fibroblast growth factor
Process	GO:0071840	Cellular component organization or biogenesis
Process	GO:0071863	Regulation of cell proliferation in bone marrow
Process	GO:0071864	Positive regulation of cell proliferation in bone marrow
Process	GO:0071865	Regulation of apoptotic process in bone marrow cell
Process	GO:0071866	Negative regulation of apoptotic process in bone marrow cell
Process	GO:0072001	Renal system development
Process	GO:0072073	Kidney epithelium development
Process	GO:0072163	Mesonephric epithelium development
Process	GO:0072164	Mesonephric tubule development
Process	GO:0072175	Epithelial tube formation
Process	GO:0072359	Circulatory system development
Process	GO:0080090	Regulation of primary metabolic process
Process	GO:0090263	Positive regulation of canonical Wnt signaling pathway
Process	GO:0090596	Sensory organ morphogenesis
Process	GO:0097094	Craniofacial suture morphogenesis
Process	GO:0097305	Response to alcohol
Process	GO:0097479	Synaptic vesicle localization
Process	GO:0098773	Skin epidermis development
Process	GO:0098868	Bone growth
Process	GO:0110148	Biomineralization
Process	GO:0120036	Plasma membrane bounded cell projection organization
Process	GO:0120039	Plasma membrane bounded cell projection morphogenesis
Process	GO:0150063	Visual system development
Process	GO:1901564	Organonitrogen compound metabolic process
Process	GO:1901700	Response to oxygen-containing compound
Process	GO:1901701	Cellular response to oxygen-containing compound
Process	GO:1902531	Regulation of intracellular signal transduction
Process	GO:1902533	Positive regulation of intracellular signal transduction
Process	GO:1902679	Negative regulation of RNA biosynthetic process
Process	GO:1902680	Positive regulation of RNA biosynthetic process
Process	GO:1903506	Regulation of nucleic acid-templated transcription
Process	GO:1903507	Negative regulation of nucleic acid-templated transcription
Process	GO:1903508	Positive regulation of nucleic acid-templated transcription
Process	GO:1904888	Cranial skeletal system development
Process	GO:2000026	Regulation of multicellular organismal development
Process	GO:2000794	Regulation of epithelial cell proliferation involved in lung morphogenesis
Process	GO:2001141	Regulation of RNA biosynthetic process
Process	GO:0035602	Fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell
Process	GO:0035603	Fibroblast growth factor receptor signaling pathway involved in hemopoiesis
Process	GO:0035604	Fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow
Process	GO:0060365	Coronal suture morphogenesis
Component	GO:0005622	Intracellular anatomical structure
Component	GO:0005634	Nucleus
Component	GO:0005737	Cytoplasm
Component	GO:0005886	Plasma membrane
Component	GO:0005887	Integral component of plasma membrane
Component	GO:0005938	Cell cortex
Component	GO:0009986	Cell surface
Component	GO:0016020	Membrane
Component	GO:0016021	Integral component of membrane
Component	GO:0030054	Cell junction
Component	GO:0030312	External encapsulating structure
Component	GO:0031012	Extracellular matrix
Component	GO:0031224	Intrinsic component of membrane
Component	GO:0031226	Intrinsic component of plasma membrane
Component	GO:0032991	Protein-containing complex
Component	GO:0043226	Organelle
Component	GO:0043227	Membrane-bounded organelle
Component	GO:0043229	Intracellular organelle
Component	GO:0043231	Intracellular membrane-bounded organelle
Component	GO:0043235	Receptor complex
Component	GO:0045202	Synapse
Component	GO:0060076	Excitatory synapse
Component	GO:0062023	Collagen-containing extracellular matrix
Component	GO:0071944	Cell periphery
Component	GO:0110165	Cellular anatomical entity
Function	GO:0000166	Nucleotide binding
Function	GO:0003824	Catalytic activity
Function	GO:0004672	Protein kinase activity
Function	GO:0004713	Protein tyrosine kinase activity
Function	GO:0004714	Transmembrane receptor protein tyrosine kinase activity
Function	GO:0004888	Transmembrane signaling receptor activity
Function	GO:0005007	Fibroblast growth factor receptor activity
Function	GO:0005488	Binding
Function	GO:0005515	Protein binding
Function	GO:0005524	ATP binding
Function	GO:0016301	Kinase activity
Function	GO:0016740	Transferase activity
Function	GO:0016772	Transferase activity, transferring phosphorus-containing groups
Function	GO:0016773	Phosphotransferase activity, alcohol group as acceptor
Function	GO:0017076	Purine nucleotide binding
Function	GO:0017134	Fibroblast growth factor binding
Function	GO:0019199	Transmembrane receptor protein kinase activity
Function	GO:0019838	Growth factor binding
Function	GO:0030554	Adenyl nucleotide binding
Function	GO:0032553	Ribonucleotide binding
Function	GO:0032555	Purine ribonucleotide binding
Function	GO:0032559	Adenyl ribonucleotide binding
Function	GO:0035639	Purine ribonucleoside triphosphate binding
Function	GO:0036094	Small molecule binding
Function	GO:0038023	Signaling receptor activity
Function	GO:0042802	Identical protein binding
Function	GO:0042803	Protein homodimerization activity
Function	GO:0043167	Ion binding
Function	GO:0043168	Anion binding
Function	GO:0046983	Protein dimerization activity
Function	GO:0060089	Molecular transducer activity
Function	GO:0097159	Organic cyclic compound binding
Function	GO:0097367	Carbohydrate derivative binding
Function	GO:0140096	Catalytic activity, acting on a protein
Function	GO:1901265	Nucleoside phosphate binding
Function	GO:1901363	Heterocyclic compound binding

Pathway annotation

Category	Term ID	Term description
RCTM	RNO-109704	PI3K Cascade
RCTM	RNO-112399	IRS-mediated signalling
RCTM	RNO-1257604	PIP3 activates AKT signaling
RCTM	RNO-162582	Signal Transduction
RCTM	RNO-190236	Signaling by FGFR
RCTM	RNO-190241	FGFR2 ligand binding and activation
RCTM	RNO-190375	FGFR2c ligand binding and activation
RCTM	RNO-190377	FGFR2b ligand binding and activation
RCTM	RNO-199418	Negative regulation of the PI3K/AKT network
RCTM	RNO-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
RCTM	RNO-2428924	IGF1R signaling cascade
RCTM	RNO-2428928	IRS-related events triggered by IGF1R
RCTM	RNO-5654221	Phospholipase C-mediated cascade; FGFR2
RCTM	RNO-5654695	PI-3K cascade:FGFR2
RCTM	RNO-5654696	Downstream signaling of activated FGFR2
RCTM	RNO-5654699	SHC-mediated cascade:FGFR2
RCTM	RNO-5654700	FRS-mediated FGFR2 signaling
RCTM	RNO-5654727	Negative regulation of FGFR2 signaling
RCTM	RNO-5654738	Signaling by FGFR2
RCTM	RNO-5673001	RAF/MAP kinase cascade
RCTM	RNO-5683057	MAPK family signaling cascades
RCTM	RNO-5684996	MAPK1/MAPK3 signaling
RCTM	RNO-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
RCTM	RNO-74751	Insulin receptor signalling cascade
RCTM	RNO-74752	Signaling by Insulin receptor
RCTM	RNO-9006925	Intracellular signaling by second messengers
RCTM	RNO-9006934	Signaling by Receptor Tyrosine Kinases
WikiPathways	WP351	Regulation of actin cytoskeleton
WikiPathways	WP358	MAPK signaling pathway
KEGG	rno01521	EGFR tyrosine kinase inhibitor resistance
KEGG	rno04010	MAPK signaling pathway
KEGG	rno04014	Ras signaling pathway
KEGG	rno04015	Rap1 signaling pathway
KEGG	rno04020	Calcium signaling pathway
KEGG	rno04144	Endocytosis
KEGG	rno04151	PI3K-Akt signaling pathway
KEGG	rno04550	Signaling pathways regulating pluripotency of stem cells
KEGG	rno04810	Regulation of actin cytoskeleton
KEGG	rno05200	Pathways in cancer
KEGG	rno05215	Prostate cancer
KEGG	rno05226	Gastric cancer
KEGG	rno05230	Central carbon metabolism in cancer

Expression profile of Fgfr2 in omics data

ID	GSE100499
Title	Exploring acupuncture mechanism in preconditioning of IRI
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM2685201	MX1	tissue: Myocardium gender: male	6.73134005
GSM2685202	MX2	tissue: Myocardium gender: female	6.744250575
GSM2685203	MX3	tissue: Myocardium gender: female	6.7781282
GSM2685204	MX4	tissue: Myocardium gender: male	7.143902925
GSM2685205	DZ1	tissue: Myocardium gender: male	6.8678348
GSM2685206	DZ2	tissue: Myocardium gender: male	6.706771525
GSM2685207	DZ3	tissue: Myocardium gender: female	6.827786275
GSM2685208	DZ4	tissue: Myocardium gender: female	6.850741675
GSM2685209	JJ1	tissue: Myocardium gender: male	6.96531225
GSM2685210	JJ2	tissue: Myocardium gender: female	6.9084322
GSM2685211	JJ3	tissue: Myocardium gender: female	7.1339503749999995
GSM2685212	JJ4	tissue: Myocardium gender: male	7.099215924999999
GSM2685213	NG1	tissue: Myocardium gender: male	6.868233875
GSM2685214	NG2	tissue: Myocardium gender: female	6.900267425
GSM2685215	NG3	tissue: Myocardium gender: male	7.0426575
GSM2685216	NG4	tissue: Myocardium gender: female	6.985749275
GSM2685217	YL1	tissue: Myocardium gender: male	6.7553588
GSM2685218	YL2	tissue: Myocardium gender: male	6.606307375
GSM2685219	YL3	tissue: Myocardium gender: female	6.8258166
GSM2685220	YL4	tissue: Myocardium gender: female	7.0006463750000005
GSM2685221	QC1	tissue: Myocardium gender: male	6.645354525
GSM2685222	QC2	tissue: Myocardium gender: male	6.724663925
GSM2685223	QC3	tissue: Myocardium gender: female	6.702968374999999
GSM2685224	QC4	tissue: Myocardium gender: female	6.763196525

ID	GSE136833
Title	Effects of lidocaine on the expression of rat spinal cord
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM4058984	Control_1	strain: Sprague-Dawley tissue: Lumbar segment of spinal cord	7.308665314
GSM4058985	Control_2	strain: Sprague-Dawley tissue: Lumbar segment of spinal cord	7.335239065
GSM4058986	Control_3	strain: Sprague-Dawley tissue: Lumbar segment of spinal cord	7.36348429
GSM4058987	Lidocaine_1	strain: Sprague-Dawley tissue: Lumbar segment of spinal cord	7.141056395
GSM4058988	Lidocaine_2	strain: Sprague-Dawley tissue: Lumbar segment of spinal cord	6.899842998
GSM4058989	Lidocaine_3	strain: Sprague-Dawley tissue: Lumbar segment of spinal cord	6.870024297

ID	GSE138454
Title	Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM4108997	Sample 1 Isoflurane sepsis	anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male	777.0
GSM4108998	Sample 2 Isoflurane sepsis	anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male	514.0
GSM4108999	Sample 3 Isoflurane sepsis	anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male	467.0
GSM4109000	Sample 4 Isoflurane sepsis	anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male	554.0
GSM4109001	Sample 5 Isoflurane control	anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male	718.0
GSM4109002	Sample 6 Isoflurane control	anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male	726.0
GSM4109003	Sample 7 Isoflurane control	anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male	815.0
GSM4109004	Sample 8 Isoflurane control	anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male	1620.0
GSM4109005	Sample9 Propofol sepsis	anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male	484.0
GSM4109006	Sample10 Propofol sepsis	anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male	433.0
GSM4109007	Sample11 Propofol sepsis	anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male	731.0
GSM4109008	Sample12 Propofol sepsis	anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male	996.0
GSM4109009	Sample13 Propofol control	anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male	522.0
GSM4109010	Sample14 Propofol control	anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male	599.0
GSM4109011	Sample 15 Propofol control	anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male	769.0
GSM4109012	Sample16 Propofol control	anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male	648.0

ID	GSE139220
Title	Expression data from sevoflurane anesthesia treated rat
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM4134285	Brain_Control_rep1	strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus	8.659933
GSM4134286	Brain_Control_rep2	strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus	8.503559
GSM4134287	Brain_Control_rep3	strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus	8.607263
GSM4134288	Brain_Sevoflurane_rep1	strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus	8.452221
GSM4134289	Brain_Sevoflurane_rep2	strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus	8.722892
GSM4134290	Brain_Sevoflurane_rep3	strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus	8.661569

ID	GSE143895
Title	GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM4276356	dhsc01	strain: Sprague Dawley tissue: DHSC treatment: CCI	48.439
GSM4276357	dhsc03	strain: Sprague Dawley tissue: DHSC treatment: CCI	44.076
GSM4276358	dhsc05	strain: Sprague Dawley tissue: DHSC treatment: CCI	50.885
GSM4276359	dhsc13	strain: Sprague Dawley tissue: DHSC treatment: SHAM	55.807
GSM4276360	dhsc15	strain: Sprague Dawley tissue: DHSC treatment: SHAM	49.519

ID	GSE157924
Title	Regulation of acupuncture on genes in brain stem
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM4780973	Rattus_JSSZ(Sham)	tissue: Rattus brainstem of modeling treatment: Sham	6.8691448345
GSM4780974	Rattus_JXZ(Hand Acu)	tissue: Rattus brainstem of modeling treatment: Hand Acu	6.3667210907500005
GSM4780975	Rattus_MXZ(TBI)	tissue: Rattus brainstem of modeling treatment: TBI	7.185341022

ID	GSE1616
Title	Genomics of preconditioning
Organism	Rattus norvegicus

GSM	Sample info	Value
GSM27484	APC_a (anesthetic-preconditioning, 1st replicate)	81.89999999999999
GSM27485	APC_b (anesthetic-preconditioning, 2nd replicate)	73.25
GSM27486	APC_c (anesthetic-preconditioning, 3rd replicate)	83.5
GSM27487	APC_d (anesthetic-preconditioning, 4th replicate)	59.15
GSM27488	APC_e (anesthetic-preconditioning, 5th replicate)	52.6
GSM27489	APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate)	91.4
GSM27490	APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate)	56.35
GSM27491	APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate)	92.17500000000001
GSM27492	APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate)	94.0
GSM27493	APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate)	101.97500000000001
GSM27494	CTL_a (control, 1st replicate)	40.675000000000004
GSM27495	CTL_b (control, 2nd replicate)	39.15
GSM27496	CTL_c (control, 3rd replicate)	91.97500000000001
GSM27497	CTL_d (control, 4th replicate)	54.55
GSM27498	CTL_e (control, 5th replicate)	29.725
GSM27499	IPC_a (ischemic preconditioning, 1st replicate)	61.8
GSM27500	IPC_b (ischemic preconditioning, 2nd replicate)	47.699999999999996
GSM27501	IPC_c (ischemic preconditioning, 3rd replicate)	71.25
GSM27502	IPC_d (ischemic preconditioning, 4th replicate)	83.05
GSM27503	IPC_e (ischemic preconditioning, 5th replicate)	90.27499999999999
GSM27504	IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate)	149.95
GSM27505	IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate)	91.725
GSM27506	IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate)	36.05
GSM27507	IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate)	52.87500000000001
GSM27508	IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate)	213.825
GSM27509	ISCH_a (ischemia, 1st replicate)	94.625
GSM27510	ISCH_b (ischemia, 2nd replicate)	44.449999999999996
GSM27511	ISCH_c (ischemia, 3rd replicate)	77.55
GSM27512	ISCH_d (ischemia, 4th replicate)	47.099999999999994
GSM27513	ISCH_e (ischemia, 5th replicate)	35.525

ID	GSE1779
Title	Effect of Isoflurane and LTM on basolateral amygdala
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM30790	baseline control 01	male, 275-300g	224.77499999999998
GSM30791	baseline control 02	male, 275-300g	203.42499999999998
GSM30792	baseline control 03	male, 275-300g	244.725
GSM30793	baseline control 04	male, 275-300g	185.5
GSM30794	baseline control 05	male, 275-300g	276.15
GSM30795	baseline control 06	male, 275-300g	199.775
GSM30796	baseline control 07	male, 275-300g	227.29999999999998
GSM30797	baseline control 08	male, 275-300g	242.14999999999998
GSM30798	baseline control 09	male, 275-300g	233.9
GSM30799	pain 01		216.45
GSM30800	pain 02		188.54999999999998
GSM30801	pain 03		333.75
GSM30802	pain 04		201.55
GSM30803	pain 05		229.1
GSM30804	FC 01		191.29999999999998
GSM30805	FC 02		306.375
GSM30806	FC 03		226.575
GSM30807	FC 04		228.8
GSM30808	FC 05		273.725
GSM30809	IFC 01		222.25
GSM30810	IFC 02		227.5
GSM30811	IFC 03		263.725
GSM30812	IFC 04		193.67499999999998
GSM30813	IFC 05		191.25
GSM99800	isoflurane 01	male, 275-300g	203.62499999999997
GSM99801	isoflurane 02	male, 275-300g	180.72499999999997
GSM99802	isoflurane 03	male, 275-300g	199.225
GSM99803	isoflurane 04	male, 275-300g	227.39999999999998
GSM99804	isoflurane 05	male, 275-300g	192.325

ID	GSE190472
Title	Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM5724271	model 21	Sex: female tissue: Uterine tissue condition: model	65.42975
GSM5724272	model 22	Sex: female tissue: Uterine tissue condition: model	69.52062500000001
GSM5724273	model 23	Sex: female tissue: Uterine tissue condition: model	60.09465
GSM5724274	treatment31	Sex: female tissue: Uterine tissue condition: treatment	57.344225
GSM5724275	treatment32	Sex: female tissue: Uterine tissue condition: treatment	53.114450000000005
GSM5724276	treatment33	Sex: female tissue: Uterine tissue condition: treatment	51.2324
GSM5724277	control 41	Sex: female tissue: Uterine tissue condition: control	34.583324999999995
GSM5724278	control 42	Sex: female tissue: Uterine tissue condition: control	43.716325
GSM5724279	control 43	Sex: female tissue: Uterine tissue condition: control	62.599375

ID	GSE192399
Title	Gene expression of brain regions activated by sevoflurane and propofol
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM5746332	LHb, Sevoflurane, 60mins	brain region: the lateral habenula (LHb) treatment: Sevoflurane	11.6227
GSM5746333	LHb, O2, 60mins	brain region: the lateral habenula (LHb) treatment: O2	11.5826
GSM5746334	MHb, Sevoflurane, 60mins	brain region: the medial habenula (MHb) treatment: Sevoflurane	9.9957
GSM5746335	MHb, O2, 60mins	brain region: the medial habenula (MHb) treatment: O2	9.61322
GSM5746336	Sol, Sevoflurane, 60mins	brain region: the solitary nucleus (Sol) treatment: Sevoflurane	10.4706
GSM5746337	Sol, O2, 60mins	brain region: the solitary nucleus (Sol) treatment: O2	10.493
GSM5746338	Mve, Sevoflurane, 60mins	brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane	10.5991
GSM5746339	Mve, O2, 60mins	brain region: the medial vestibular nucleus (MVe) treatment: O2	10.3304
GSM5746340	LHb, Propofol, 60mins	brain region: the lateral habenula (LHb) treatment: Propofol	10.9305
GSM5746341	LHb, Intralipos, 60mins	brain region: the lateral habenula (LHb) treatment: Intralipos	10.7648
GSM5746342	MHb, Propofol, 60mins	brain region: the medial habenula (MHb) treatment: Propofol	9.6727
GSM5746343	MHb, Intralipos, 60mins	brain region: the medial habenula (MHb) treatment: Intralipos	9.6748
GSM5746344	Sol, Propofol, 60mins	brain region: the solitary nucleus (Sol) treatment: Propofol	9.69126
GSM5746345	Sol, Intralipos, 60mins	brain region: the solitary nucleus (Sol) treatment: Intralipos	9.83013
GSM5746346	MVe, Propofol, 60mins	brain region: the medial vestibular nucleus (MVe) treatment: Propofol	10.2878
GSM5746347	MVe, Intralipos, 60mins	brain region: the medial vestibular nucleus (MVe) treatment: Intralipos	10.2344

ID	GSE205202
Title	Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM6208507	Rat_Baseline_0h_1	tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0	6.376994
GSM6208508	Rat_Baseline_0h_2	tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0	6.534637
GSM6208509	Rat_Baseline_0h_3	tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0	6.449611
GSM6208510	Rat_Baseline_0h_4	tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0	6.446707
GSM6208511	Rat_Baseline_0h_5	tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0	6.403457
GSM6208512	Rat_Vehicle_03h_1	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3	6.486894
GSM6208513	Rat_Vehicle_03h_2	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3	6.531449
GSM6208514	Rat_Vehicle_03h_3	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3	6.49136
GSM6208515	Rat_Vehicle_03h_4	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3	6.455055
GSM6208516	Rat_Vehicle_03h_5	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3	6.495192
GSM6208517	Rat_Vehicle_06h_1	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6	6.534178
GSM6208518	Rat_Vehicle_06h_2	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6	6.550719
GSM6208519	Rat_Vehicle_06h_3	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6	6.768563
GSM6208520	Rat_Vehicle_06h_4	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6	6.614835
GSM6208521	Rat_Vehicle_06h_5	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6	6.538929
GSM6208522	Rat_Vehicle_09h_1	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9	6.488122
GSM6208523	Rat_Vehicle_09h_2	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9	6.483329
GSM6208524	Rat_Vehicle_09h_3	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9	6.635041
GSM6208525	Rat_Vehicle_09h_4	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9	6.595358
GSM6208526	Rat_Vehicle_09h_5	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9	6.502352
GSM6208527	Rat_Vehicle_24h_1	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24	6.39272
GSM6208528	Rat_Vehicle_24h_2	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24	6.519543
GSM6208529	Rat_Vehicle_24h_3	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24	6.443111
GSM6208530	Rat_Vehicle_24h_4	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24	6.471515
GSM6208531	Rat_Vehicle_24h_5	tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24	6.588751
GSM6208532	Rat_APAP_03h_1	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3	6.334365
GSM6208533	Rat_APAP_03h_2	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3	6.421517
GSM6208534	Rat_APAP_03h_3	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3	6.394954
GSM6208535	Rat_APAP_03h_4	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3	6.31003
GSM6208536	Rat_APAP_03h_5	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3	6.3286
GSM6208537	Rat_APAP_06h_1	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6	6.305305
GSM6208538	Rat_APAP_06h_2	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6	6.400389
GSM6208539	Rat_APAP_06h_3	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6	6.222485
GSM6208540	Rat_APAP_06h_4	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6	6.270194
GSM6208541	Rat_APAP_06h_5	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6	6.329287
GSM6208542	Rat_APAP_09h_1	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9	6.36049
GSM6208543	Rat_APAP_09h_2	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9	6.304513
GSM6208544	Rat_APAP_09h_3	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9	6.274464
GSM6208545	Rat_APAP_09h_4	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9	6.350085
GSM6208546	Rat_APAP_09h_5	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9	6.370286
GSM6208547	Rat_APAP_24h_1	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24	6.505826
GSM6208548	Rat_APAP_24h_2	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24	6.430154
GSM6208549	Rat_APAP_24h_3	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24	6.367755
GSM6208550	Rat_APAP_24h_4	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24	6.402997
GSM6208551	Rat_APAP_24h_5	tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24	6.326864

ID	GSE232804
Title	EGR3 regulates opioid-related nociception and motivation in male rats
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM7383519	ww01_Saline_Saline	tissue: Brain / mPFC pain: Saline drug: Salin	527.0
GSM7383520	ww02_Saline_Saline	tissue: Brain / mPFC pain: Saline drug: Saline	558.0
GSM7383521	ww03_Saline_Saline	tissue: Brain / mPFC pain: Saline drug: Salin	530.0
GSM7383522	ww05_Saline_Saline	tissue: Brain / mPFC pain: Saline drug: Saline	508.0
GSM7383523	ww06_Saline_Saline	tissue: Brain / mPFC pain: Saline drug: Salin	562.0
GSM7383524	ww07_Saline_Saline	tissue: Brain / mPFC pain: Saline drug: Saline	476.0
GSM7383525	ww08_Saline_Saline	tissue: Brain / mPFC pain: Saline drug: Salin	569.0
GSM7383526	ww10_Saline_Saline	tissue: Brain / mPFC pain: Saline drug: Saline	561.0
GSM7383527	ww12_Saline_OXY	tissue: Brain / mPFC pain: Saline drug: OXY	442.0
GSM7383528	ww13_Saline_OXY	tissue: Brain / mPFC pain: Saline drug: OXY	787.0
GSM7383529	ww14_Saline_OXY	tissue: Brain / mPFC pain: Saline drug: OXY	526.0
GSM7383530	ww15_Saline_OXY	tissue: Brain / mPFC pain: Saline drug: OXY	552.0
GSM7383531	ww16_Saline_OXY	tissue: Brain / mPFC pain: Saline drug: OXY	548.0
GSM7383532	ww17_Saline_OXY	tissue: Brain / mPFC pain: Saline drug: OXY	731.0
GSM7383533	ww18_Saline_OXY	tissue: Brain / mPFC pain: Saline drug: OXY	738.0
GSM7383534	ww20_Saline_OXY	tissue: Brain / mPFC pain: Saline drug: OXY	528.0
GSM7383535	ww21_CFA_Saline	tissue: Brain / mPFC pain: CFA drug: Saline	749.0
GSM7383536	ww22_CFA_Saline	tissue: Brain / mPFC pain: CFA drug: Saline	546.0
GSM7383537	ww23_CFA_Saline	tissue: Brain / mPFC pain: CFA drug: Saline	477.0
GSM7383538	ww24_CFA_Saline	tissue: Brain / mPFC pain: CFA drug: Saline	490.0
GSM7383539	ww26_CFA_Saline	tissue: Brain / mPFC pain: CFA drug: Saline	589.0
GSM7383540	ww27_CFA_Saline	tissue: Brain / mPFC pain: CFA drug: Saline	865.0
GSM7383541	ww28_CFA_Saline	tissue: Brain / mPFC pain: CFA drug: Saline	910.0
GSM7383542	ww30_CFA_Saline	tissue: Brain / mPFC pain: CFA drug: Saline	718.0
GSM7383543	ww31_CFA_OXY	tissue: Brain / mPFC pain: CFA drug: OXY	643.0
GSM7383544	ww32_CFA_OXY	tissue: Brain / mPFC pain: CFA drug: OXY	563.0
GSM7383545	ww34_CFA_OXY	tissue: Brain / mPFC pain: CFA drug: OXY	566.0
GSM7383546	ww35_CFA_OXY	tissue: Brain / mPFC pain: CFA drug: OXY	602.0
GSM7383547	ww36_CFA_OXY	tissue: Brain / mPFC pain: CFA drug: OXY	695.0
GSM7383548	ww37_CFA_OXY	tissue: Brain / mPFC pain: CFA drug: OXY	570.0
GSM7383549	ww38_CFA_OXY	tissue: Brain / mPFC pain: CFA drug: OXY	614.0
GSM7383550	www09_Saline_Saline	tissue: Brain / mPFC pain: Saline drug: Saline	784.0
GSM7383551	www19_Saline_OXY	tissue: Brain / mPFC pain: Saline drug: OXY	670.0
GSM7383552	www29_CFA_Saline	tissue: Brain / mPFC pain: CFA drug: Saline	591.0
GSM7383553	www33_CFA_OXY	tissue: Brain / mPFC pain: CFA drug: OXY	592.0
GSM7383554	www39_CFA_OXY	tissue: Brain / mPFC pain: CFA drug: OXY	475.0

ID	GSE244436
Title	Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM7816143	Liver, Control for SevoAnes	tissue: liver genotype: wild type treatment: Control for SevoAnes	24.486832
GSM7816144	Liver, Anesthetized with sevoflurane for 6 h	tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h	16.746078
GSM7816145	Liver, Control for DesAnes	tissue: liver genotype: wild type treatment: Control for DesAnes	24.904726
GSM7816146	Liver, Anesthetized with desflurane for 6 h	tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h	21.911371

ID	GSE2982
Title	Effect of inhaled anesthetic to cultured cortical neurons
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM61779	Cell Culture Exposure (control1)	Cy3 label;Cy5;	0.07095
GSM61796	Cell Culture Exposure (control2)	Cy3; Cy5	-0.0795
GSM61797	Cell Culture Exposure (control3)	Cy3; Cy5	0.0771
GSM61798	Cell Culture Exposure (1MAC Halo1)	Cy3; Cy5	-0.17784999999999998
GSM61799	Cell Culture Exposure (1MAC Halo2)	Cy3; Cy5	-0.0033999999999999994
GSM61800	Cell Culture Exposure (1MAC Halo3)	Cy3; Cy5	-0.038044999999999995
GSM61801	Cell Culture Exposure (3MAC Halo1)	Cy3; Cy5	-0.15295
GSM61802	Cell Culture Exposure (3MAC Halo2)	Cy3; Cy5	-0.26849999999999996
GSM61803	Cell Culture Exposure (3MAC Halo3)	Cy3; Cy5	-0.1815
GSM61804	Cell Culture Exposure (3MAC ISO1)	Cy3; Cy5	-0.05985
GSM61805	Cell Culture Exposure (3MAC ISO2)	Cy3; Cy5	-0.237
GSM61806	Cell Culture Exposure (3MAC ISO3)	Cy3; Cy5	-0.05095

ID	GSE359
Title	Isoflurane Single Exposures
Organism	Rattus norvegicus

GSM	Sample info	Value
GSM5120	Isoflurane single exposure control-1	34.15
GSM5121	Isoflurane single exposure control-2	33.0
GSM5122	Isoflurane single exposure control-3	21.55
GSM5124	Isoflurane single exposure 1 hr-1	28.55
GSM5126	Isoflurane single exposure 1 hr-2	59.8
GSM5127	Isoflurane single exposure 2 hr-1	33.15
GSM5130	Isoflurane single exposure 2 hr-2	40.4
GSM5131	Isoflurane single exposure 2 hr-3	39.725

ID	GSE48025
Title	Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM1165929	RAT_NORA_T0_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy	3.70319663075
GSM1165930	RAT_NORA_T0_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy	3.66207679125
GSM1165931	RAT_RA_T0_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy	3.75736190925
GSM1165932	RAT_RA_T0_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy	3.643668367
GSM1165933	RAT_NORA_1h_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy	3.52226648
GSM1165934	RAT_NORA_1h_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy	3.7379214152499998
GSM1165935	RAT_AP_1h_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy	4.02285480275
GSM1165936	RAT_AP_1h_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy	3.60675056975
GSM1165937	RAT_MTX_1h_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy	3.5253036495
GSM1165938	RAT_MTX_1h_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy	3.410175671
GSM1165939	RAT_ANE_1h_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy	3.8424496367499996
GSM1165940	RAT_ANE_1h_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy	3.7311840125
GSM1165941	RAT_PLA_1h_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy	3.49751110125
GSM1165942	RAT_PLA_1h_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy	3.92173528
GSM1165943	RAT_NORA_34d_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy	3.6748909842499997
GSM1165944	RAT_NORA_34d_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy	3.8293181352500003
GSM1165945	RAT_AP_34d_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy	4.057005141
GSM1165946	RAT_AP_34d_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy	3.7915083684999997
GSM1165947	RAT_MTX_34d_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy	3.7099577032499997
GSM1165948	RAT_MTX_34d_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy	3.6533841555
GSM1165949	RAT_ANE_34d_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy	3.756711876
GSM1165950	RAT_ANE_34d_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy	3.6734875205
GSM1165951	RAT_PLA_34d_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy	3.7666757305000003
GSM1165952	RAT_PLA_34d_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy	3.7403615255

ID	GSE53897
Title	Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM1303240	DRG RVM1	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.685824
GSM1303241	DRG RVM2	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.681759
GSM1303242	DRG RVM3	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.764146
GSM1303243	DRG RVM7	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.71151
GSM1303244	DRG RVOx2	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.613269
GSM1303245	DRG RVOx3	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.628869
GSM1303246	DRG RVOx5	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.691343
GSM1303247	DRG RVOx7	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.707605
GSM1303248	DRG RVS4	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.524673
GSM1303249	DRG RVS5	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.681429
GSM1303250	DRG RVS6	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.706893
GSM1303251	DRG RVS7	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.819571
GSM1303252	DRG RSM1	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.700449
GSM1303253	DRG RSM2	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.838948
GSM1303254	DRG RSM4	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.787366
GSM1303255	DRG RSM5	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.655046
GSM1303256	DRG RSOx1	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.774839
GSM1303257	DRG RSOx2	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.770904
GSM1303258	DRG RSOx3	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.486237
GSM1303259	DRG RSOx4	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.621106
GSM1303260	DRG RSS1	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.583958
GSM1303261	DRG RSS2	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.569113
GSM1303262	DRG RSS3	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.811271
GSM1303263	DRG RSS6	strain: sprague-dawley age: 3 months tissue: dorsal root ganglion	5.720004

ID	GSE55573
Title	Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM1339443	Mock skeletal muscle	strain: Wistar age: 8-10 week-old gender: Male	125.6977
GSM1339444	EA (electroacupuncture) skeletal muscle	strain: Wistar age: 8-10 week-old gender: Male	127.3226

ID	GSE58456
Title	Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM1693996	Peripheral blood mononuclear cells from NORA before therapy, replicate 1	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy	37.80196049
GSM1693997	Peripheral blood mononuclear cells from NORA before therapy, replicate 2	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy	12.51516946725
GSM1693998	Peripheral blood mononuclear cells from NORA before therapy, replicate 3	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy	74.0513635325
GSM1693999	Peripheral blood mononuclear cells from RA before therapy, replicate 1	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy	42.466145221750004
GSM1694000	Peripheral blood mononuclear cells from RA before therapy, replicate 2	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy	51.066021070000005
GSM1694001	Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy	34.16111469325
GSM1694002	Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy	66.9124950755
GSM1694003	Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy	34.948191216
GSM1694004	Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy	35.06576278
GSM1694005	Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy	55.67691830175
GSM1694006	Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy	26.00748208
GSM1694007	Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy	51.906448557000004
GSM1694008	Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy	45.6009604885
GSM1694009	Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy	28.8925699025

ID	GSE58460
Title	Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM1165929	RAT_NORA_T0_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy	3.70319663075
GSM1165930	RAT_NORA_T0_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy	3.66207679125
GSM1165931	RAT_RA_T0_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy	3.75736190925
GSM1165932	RAT_RA_T0_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy	3.643668367
GSM1165933	RAT_NORA_1h_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy	3.52226648
GSM1165934	RAT_NORA_1h_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy	3.7379214152499998
GSM1165935	RAT_AP_1h_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy	4.02285480275
GSM1165936	RAT_AP_1h_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy	3.60675056975
GSM1165937	RAT_MTX_1h_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy	3.5253036495
GSM1165938	RAT_MTX_1h_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy	3.410175671
GSM1165939	RAT_ANE_1h_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy	3.8424496367499996
GSM1165940	RAT_ANE_1h_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy	3.7311840125
GSM1165941	RAT_PLA_1h_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy	3.49751110125
GSM1165942	RAT_PLA_1h_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy	3.92173528
GSM1165943	RAT_NORA_34d_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy	3.6748909842499997
GSM1165944	RAT_NORA_34d_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy	3.8293181352500003
GSM1165945	RAT_AP_34d_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy	4.057005141
GSM1165946	RAT_AP_34d_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy	3.7915083684999997
GSM1165947	RAT_MTX_34d_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy	3.7099577032499997
GSM1165948	RAT_MTX_34d_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy	3.6533841555
GSM1165949	RAT_ANE_34d_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy	3.756711876
GSM1165950	RAT_ANE_34d_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy	3.6734875205
GSM1165951	RAT_PLA_34d_1	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy	3.7666757305000003
GSM1165952	RAT_PLA_34d_2	gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy	3.7403615255
GSM1412003	RAT_NORA_T0_1	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004	RAT_NORA_T0_2	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005	RAT_RA_T0_1	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006	RAT_RA_T0_2	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007	RAT_NORA_1h_1	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008	RAT_NORA_1h_2	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009	RAT_AP_1h_1	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010	RAT_AP_1h_2	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011	RAT_MTX_1h_1	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012	RAT_MTX_1h_2	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013	RAT_ANE_1h_1	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014	RAT_ANE_1h_2	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015	RAT_PLA_1h_1	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016	RAT_PLA_1h_2	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017	RAT_NORA_34d_1	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018	RAT_NORA_34d_2	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019	RAT_AP_34d_1	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020	RAT_AP_34d_2	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021	RAT_MTX_34d_1	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022	RAT_MTX_34d_2	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023	RAT_ANE_34d_1	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024	RAT_ANE_34d_2	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025	RAT_PLA_34d_1	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026	RAT_PLA_34d_2	strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027	RAT_RA_T0_1	strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028	RAT_RA_T0_2	strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029	RAT_AP_1h_1	strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030	RAT_AP_1h_2	strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031	RAT_PLA_1h_1	strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032	RAT_PLA_1h_2	strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033	RAT_AP_34d_1	strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034	RAT_AP_34d_2	strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035	RAT_PLA_34d_1	strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036	RAT_PLA_34d_2	strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996	Peripheral blood mononuclear cells from NORA before therapy, replicate 1	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap	37.80196049
GSM1693997	Peripheral blood mononuclear cells from NORA before therapy, replicate 2	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy	12.51516946725
GSM1693998	Peripheral blood mononuclear cells from NORA before therapy, replicate 3	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy	74.0513635325
GSM1693999	Peripheral blood mononuclear cells from RA before therapy, replicate 1	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy	42.466145221750004
GSM1694000	Peripheral blood mononuclear cells from RA before therapy, replicate 2	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy	51.066021070000005
GSM1694001	Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy	34.16111469325
GSM1694002	Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap	66.9124950755
GSM1694003	Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy	34.948191216
GSM1694004	Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy	35.06576278
GSM1694005	Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy	55.67691830175
GSM1694006	Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy	26.00748208
GSM1694007	Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy	51.906448557000004
GSM1694008	Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy	45.6009604885
GSM1694009	Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3	strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy	28.8925699025

ID	GSE752
Title	Halothane/Isoflurane Repetitive Exposures
Organism	Rattus norvegicus

GSM	Sample info	Value
GSM5082	Control 1	67.875
GSM5084	Control 2	84.375
GSM5085	Control 3	66.975
GSM5086	Control 4	88.425
GSM5087	Control 5	70.6
GSM5090	Control 6	92.875
GSM5105	Control 7	85.875
GSM5106	Control 8	76.875
GSM5107	Control 9	68.075
GSM5108	Halothane 10 exposure-1	71.8
GSM5109	Halothane 10 exposures-2	79.15
GSM5110	Halothane 10 exposures-3	56.525000000000006
GSM5111	Halothane 5 exposures-1	68.225
GSM5112	Halothane 5 exposures-2	94.47500000000001
GSM5113	Halothane 5 exposures-3	48.1
GSM5114	Isoflurane 10 exposures-1	64.175
GSM5115	Isoflurane 10 exposures-2	103.525
GSM5116	Isoflurane 10 exposures-3	57.65
GSM5117	Isoflurane 5 exposures-1	84.07499999999999
GSM5118	Isoflurane 5 exposures-2	89.4
GSM5119	Isoflurane 5 exposures-3	56.1
GSM11379	Control 10	61.225
GSM11380	Control 11	77.175
GSM11381	Control 12	43.225

ID	GSE8911
Title	Skeletal muscle after fine needle stimulation
Organism	Rattus norvegicus

GSM	Sample info	Characteristics	Value
GSM225891	Skeletal muscle sample from fine needle-stimulated hindlimb	Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb	11.03752675
GSM225892	Skeletal muscle sample from control hindlimb	Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb	9.186620000000001